Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia

Blood Cells, Molecules, and Diseases

Volumn 45, Issue 4, 2010, Pages 289-292

  Maier Redelsperger, Micheline ^a,b,c   Lévy, Pierre ^a,c   Lionnet, François ^a   Stankovic, Katia ^a   Haymann, Jean Philippe ^a   Lefèvre, Guillaume ^a   Avellino, Virginie ^a   Perol, Jean Pierre ^d   Girot, Robert ^a,b,c   Elion, Jacques ^c,e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d SYSMEX CORPORATION   (Japan)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Glomerulopathy; Hemolysis; Red blood cells; Sickle cell anemia

Indexed keywords

ALPHA GLOBIN; BILIRUBIN; BIOCHEMICAL MARKER; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; ALBUMINURIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL MATURATION; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE LIFESPAN; GLOMERULOPATHY; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; MICROCYTOSIS; PREDICTION; PRIORITY JOURNAL; RETICULOCYTE COUNT; RETICULOCYTE HEMOGLOBIN CONTENT; RISK ASSESSMENT; SICKLE CELL ANEMIA;

ALBUMINURIA; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; CELL SURVIVAL; ERYTHROCYTES; GLOMERULONEPHRITIS; HEMOGLOBINS; HEMOLYSIS; HUMANS; L-LACTATE DEHYDROGENASE; RETICULOCYTES;

EID: 78649444537     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.08.001     Document Type: Article

References (31)

1. Powars D.R., Chan L.S., Hiti A., Ramicone E., Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine 2005, 84:363-376.
2. Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med 1990, 150:501-504.
3. Serjeant G.R., Higgs D.R., Hambleton I.R. Elderly survivors with homozygous sickle cell disease. N Engl J Med 2007, 356:642-643.
4. Kato G.J., Gladwin M.T., Steinberg M.H. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews 2007, 21:37-47.
5. Kato G.J., Wang Z., Machado R.F., Blackwelder W.C., Taylor J.G., Hazen S.L. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br J Haematol 2009, 145:506-513.
6. Kato G.J., McGowan V., Machado R.F., Little J.A., Taylor J., Morris C.R., Nichols J.S., Wang X., Poljakovic M., Morris S.M., Gladwin M.T. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006, 107:2279-2285.
7. Nolan V.G., Wyszynski D.F., Farrer L.A., Steinberg M.H. Hemolysis-associated priapism in sickle cell disease. Blood 2005, 106:3264-3267.
8. Nolan V.G., Adewoye A., Baldwin C., Wang L., Ma Q., Wyszynski D.F., Farrell J.J., Sebastiani P., Farrer L.A., Steinberg M.H. Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol 2006, 133:570-578.
9. Morris C.R. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program 2008, 177-185.
10. Haymann J.P., Stankovic K., Lévy P., Avellino V., Tharaux P.L., Letavernier E., Grateau G., Baud L., Girot R., Lionnet F. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol 2010, 5:756-761.
11. Becton L.J., Kalpatthi R.V., Rackoff E., Disco D., Orak J.K., Jackson S.M., Shatat I.F. Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 2010, 25:1505-1511.
12. Gurkan S., Scarponi K.J., Hotchkiss H., Savage B., Drachtman R. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol Jun 2 2010, [Epub ahead of print].
13. Guasch A., Navarrete J., Nass K., Zayas C.F. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 2006, 17:2228-2235.
14. Ataga K.I., Brittain J.E., Moore D., Jones S.K., Hulkower B., Strayhorn D., Adam S., Redding-Lallinger R., Nachman P., Orringer E.P. Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble FMS-like tyrosine kinase-1. Eur J Haematol May 14 2010, [Epub ahead of print].
15. Riley R.S., Ben-Ezra J.M., Goel R., Tidwell A. Reticulocytes and reticulocyte enumeration. Journal of Clinical Laboratory Analysis 2001, 15:267-294.
16. Bain B. Performing a blood count. Blood Cells: A Practical Guide 2006, 20-60. Blackwell Publishing Asia Pty Ltd, Australia. B. Bain (Ed.).
17. Powars D.R., Elliott-Mills D.D., Chan L., Niland J., Hiti A.L., Opas L.M., Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Annals of Internal Medicine 1991, 115:614-620.
18. Taylor J.G., Nolan V.G., Mendelsohn L., Kato G.J., Gladwin M.T., Steinberg M.H. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS ONE 2008, 3:e2095.
19. Maier-Redelsperger M., Flahault A., Neonato M.G., Girot R., Labie D. Automated analysis of mature red blood cells and reticulocytes in SS and SC disease. Blood Cells Mol Dis 2004, 33:15-24.
20. Nagel R.L., Platt O.S. General pathophysiology of sickle cell anemia. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management 2001, 494-526. Cambridge University Press. M.H. Steinberg, B.G. Forget, D.R. Higgs, R.L. Nagel (Eds.).
21. Brugnara C., Zelmanovic D., Sorette M., Ballas S.K., Platt O. Reticulocyte hemoglobin, an integrated parameter for evaluation of erythropoietic activity. Am J Clin Pathol 1997, 108:133-142.
22. Dode C., Krishnamoorthy R., Lamb J., Rochette J. Rapid analysis of α3.7 triplication by enzymatic amplification analysis. Br J Haematol 1992, 82:105-111.
23. Buttarello M., Temporin V., Ceravolo R., Farina G., Bulian P. The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100. Its use in the diagnosis and monitoring of posttreatment sideropenic anemia. Am J Clin Pathol 2004, 121:489-495.
24. Buttarello M., Plebani M. Automated blood cell counts, state of the art. Am J Clin Pathol 2008, 130:104-116.
25. Franck S., Linssen J., Messinger M., Thomas L. Potential utility of Ret-Y in the diagnosis of iron-restricted erythropoiesis. Clin Chem 2004, 50:1240-1242.
26. Brugnara C., Schiller B., Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haem 2006, 28:303-308.
27. Embury S.H., Dozy A.M., Miller J., Davis J.R., Kleman K.M., Preisler H., Vichinsky E., Lande W.N., Lubin B.H., Kan Y.W., Mentzer W.C. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. N Engl J Med 1982, 306:270-274.
28. Bunn H.F., Nathan D.G., Dover G.J., Hebbel R.P., Platt O.S., Rosse W.F., Ware R.E. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood May 14 2010, [Epub ahead of print].
29. Cumming V., King L., Fraser R., Serjeant G., Reid M. Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia. Br J Haematol 2008, 142:119-125.
30. Guasch A., Zayas C.F., Eckman J.R., Muralidharan K., Zhang W., Elsas L.J. Evidence that microdeletions in the α globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol 1999, 10:1014-1019.
31. Nebor D., Broquere C., Brudey K., Mougenel D., Tarer V., Connes P., Elion J., Romana M. Alpha-thalassemia is associated with a decreased occurrence and a delayed age-at-onset of albuminuria in sickle cell anemia patients. Blood Cells Mol Dis Jul 1 2010, [Epub ahead of print].